Firms

Kaleida Capital

Kaleida Capital

San Diego, California, US

Kaleida Capital invests in NeuroAI, where neuroscience, neural interfaces and artificial intelligence meet. Its focus includes brain-computer interfaces, neural data, neuromodulation, precision therapeutics and computing systems inspired by biological intelligence.

Founded
—
Type
Venture capital

Funds1

  • Kaleida Capital Fund I—

    Early-stage NeuroAI and neurotechnology fund. Initial Form D filed in February 2026, with an amendment in June 2026. The firm offers diversified exposure to neural interfaces, neuroscience and AI; fund size and final closing date remain undisclosed.

Team

Max Hodak
Max Hodak

Kaleida Capital, Scientific Advisory Council Member

—— – —

Operations and support

Sergey StaviskySergey StaviskyScientific Advisory Council Member
Ariane TomAriane TomFounder and Managing Director
Edward WoodScientific Advisory Council Member
Evan SchnellEvan SchnellVenture Partner
Justin TrotterScientific Advisory Council Member
Kevin CarlbergKevin CarlbergVenture Partner
Mary El-MahmoudiMary El-MahmoudiVenture Partner
Matt AngleMatt AngleScientific Advisory Council Member
Philip SabesScientific Advisory Council Member
Srihari SritharanSrihari SritharanVenture Fellow
Sumner NormanSumner NormanScientific Advisory Council Member
Thomas OxleyThomas OxleyScientific Advisory Council Member

Co-investing

Investments